Business · 28/05/1999Updated: 10/17/2026 · 1 min read
FDA Determines Regulatory Review Period for Therma Choice Uterine Ballon Therapy System
Summary
The FDA has officially confirmed the regulatory review period for the Therma Choice SUPTM Uterine Ballon Therapy System, a medical device, in response to a patent extension application submitted to the US Department of Commerce.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →